&Partners’s Doximity DOCS Stock Holding History

&Partners’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,801	Closed	-$344K	–	2421
2025 Q4	$344K	Buy	7,801 +486	+7%	+$27.3K	﹤0.01%	1836
2025 Q3	$535K	Buy	7,315 +420	+6%	+$27.4K	﹤0.01%	1410
2025 Q2	$423K	Buy	6,895 +585	+9%	+$32.6K	﹤0.01%	1436
2025 Q1	$369K	Buy	6,310 +2,007	+47%	+$127K	﹤0.01%	1300
2024 Q4	$238K	Buy	+4,303	New	+$211K	﹤0.01%	1460

Other funds holding DOCS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

&Partners's DOCS Position: Q1 2026 in Review

&Partners sold out of Doximity (DOCS) in Q1 2026, closing a stake of 7,801 shares — an estimated $344K sold.

&Partners first reported a position in DOCS in Q4 2024 and held it in 5 quarters. The position peaked at $535K in Q3 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

&Partners reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
&Partners sold 7,801 Doximity shares in Q1 2026, an estimated $344K.
&Partners first reported a position in Doximity in Q4 2024 and held it in 5 quarters.
&Partners's Doximity position peaked at $535K in Q3 2025.
419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.